SCHEMBL21632850

SCHEMBL21632850

CNCCC(Oc1ccccc1N1CCN(Cc2ccccc2)CC1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD3 P35462 3/20 0.55
▸ DRD2 P14416 1/20 0.55
▸ DRD4 P21917 1/20 0.55
▸ SLC6A2 P23975 6/20 0.54
▸ SLC6A4 P31645 5/20 0.54
▸ CYP1A2 P05177 4/20 0.54
▸ CYP3A4 P08684 4/20 0.54
▸ CYP2D6 P10635 4/20 0.54
▸ TSHR P16473 3/20 0.54
▸ SLC6A3 Q01959 3/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ CHRM1 P11229 2/20 0.54
▸ ADRA2B P18089 2/20 0.54
▸ HTR2A P28223 2/20 0.54
▸ HTR2C P28335 2/20 0.54
▸ HRH1 P35367 2/20 0.54
▸ OPRM1 P35372 2/20 0.54
▸ OPRK1 P41145 2/20 0.54
▸ HTR2B P41595 2/20 0.54
▸ KCNH2 Q12809 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21632998 0.89 ADRA1D (0.65) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21633130 0.86 SLC6A4 (0.56) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21633003 0.86 SLC6A2 (0.59) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21632837 0.86 CACNA2D1 (0.60) DRD3DRD2SLC6A2SLC6A4CYP1A2
SCHEMBL21391204 0.84 SLC6A4 (0.45) DRD3DRD2DRD4SLC6A2SLC6A4
SCHEMBL21658558 0.83 SLC6A2 (0.57) DRD3DRD2SLC6A2SLC6A4CYP1A2
SCHEMBL21633324 0.82 CACNA2D1 (0.67) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21633151 0.81 KMT2A (0.59) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21633014 0.80 SLC6A2 (0.54) DRD3SLC6A2SLC6A4CYP1A2CYP3A4
SCHEMBL21632939 0.79 SLC6A4 (0.53) DRD3DRD2SLC6A2SLC6A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO claimed
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO disclosed
WO-2020021021-A1 ORTHO SUBSTITUTED PHENOXYPROPYLAMINO AND BENZYLOXYPROPYLAMINO DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-30 — — WO disclosed
Send feedback